Full history for every metric is available with a Kvantra account

Stock profile
West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc. (WST)

Country: United States of AmericaSector: HealthcareIndustry: Medical - Instruments & SuppliesExchange: NYSE
P/E TTM
43.8
History
P/E NTM
38.0
Market cap
27.19B
Currency USD
KvantraRankAbout48
IValue18
IIQuality65
IIIMomentum74
Current price
390.30 USD-1.61%
Close 20 Nov 2026
Interval
Benchmarks

Key financial summary

Financials in USD
202020212022202320242025TTM2026E
Total revenue$m2,1472,8312,8862,9512,8933,0743,3973,419
Operating profit$m617780
Net profit$m346662586593493494639677
EPS reported$6.808.91
Operating cashflow per share$10.449.30
Capex per share$3.952.86
FCF per share$6.496.44
Free cash flow$m469453
Net debt$m-375-159
Book value equity$m3,1762,968
Book value per share$43.6941.92
Number of sharesm72.770.8
DPS (TTM paid)$0.850.92

Financial summary

Financials in USD
202020212022202320242025TTM2026E
Value
P/E TTMx40.4643.80
P/B LTMx6.269.16
P/S LTMx6.478.00
P/FCF LTMx42.4259.97
EV/EBITDA LTMx25.3327.95
EV/Sales LTMx6.357.96
Earnings Yield LTM%2.47%2.28%
FCF Yield%2.36%1.67%
Quality
ROE%15.54%21.08%
ROIC%13.62%17.89%
Operating margin%20.09%22.97%
Gross margin%35.89%37.59%
FCF/Sales%15.26%13.35%
Growth and momentum
EPS Growth YoY%+1.64%+31.80%
Sales Growth YoY%+6.26%+12.58%
Net Income Growth YoY%+0.20%+29.94%
FCF Growth%+69.65%+19.60%
Operating Profit Growth%+3.83%+23.66%
Dividend and capital structure
Dividend Yield%0.31%0.24%
Dividend Growth%+4.94%+8.24%
Payout Ratio%12.38%9.82%
FCF/Debtx1.131.49
Net Debt/EBITDAx-0.49-0.16
EBIT/Net interestx1,029.00-
Net debt/market cap%-1.88%-0.59%
Net debt/Equityx-0.12-0.05
Gross debt/equityx0.130.10

ETFs that hold West Pharmaceutical Services

FundTickerPosition#Weight
Hilton Small-MidCap Opportunity ETFSMCO52.39%
BMO Equal Weight US Health Care Hedged to CAD Index ETFZUH.TO81.31%
Virtus KAR Mid-Cap ETFKMID25.89%

Funds with West Pharmaceutical Services among their ten largest holdings, largest fund first.

Price target estimates

Low estimate
High estimate
Price consensus
Last year average price target
Current price390.30 USD
Return Potential

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating

Company overview

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

West Pharmaceutical Services, Inc. (WST)

WST · NYSE · Healthcare
390.30 USD-1.61%
Sign up to track this stock
Benchmarks
KvantraRank48
Market cap27.19B
P/E NTM38.0
P/E TTM43.8
KvantraRank?48 / 100
Value
18
Quality
65
Momentum
74
Financialsin USD
20242025TTM2026E
ETFs that hold West Pharmaceutical Services
FundTickerPosition#Weight
Hilton Small-MidCap Opportunity ETFSMCO52.39%
BMO Equal Weight US Health Care Hedged to CAD Index ETFZUH.TO81.31%
Virtus KAR Mid-Cap ETFKMID25.89%

Funds with West Pharmaceutical Services among their ten largest holdings, largest fund first.

Analyst target
Consensus
Current390.30 USD
Upside
Price consensus
Last year average price target
Current price390.30 USD
Return Potential

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating
About

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

IndustryMedical - Instruments & Supplies
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free